Re-appraisal of topical 1% voriconazole and 5% natamycin in the treatment of fungal keratitis in a randomised trial

British Journal of Ophthalmology

Volumn 99, Issue 9, 2015, Pages 1190-1195

  Sharma, Savitri ^a   Das, Sujata ^a   Virdi, Ajoy ^a   Fernandes, Merle ^a   Sahu, Srikant K ^a   Koday, Nagendra Kumar ^a   Ali, Md Hasnat ^a   Garg, Prashant ^a   Motukupally, Swapna R ^a  

^a L V PRASAD EYE INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

NATAMYCIN; VORICONAZOLE; ANTIFUNGAL AGENT; EYE DROPS;

ADULT; AGE DISTRIBUTION; ARTICLE; ASPERGILLUS; ASPERGILLUS KERATITIS; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; CORNEA DISEASE; CORNEA ULCER; CORNEAL EPITHELIAL DEFECT; CORNEAL INFILTRATE; DISEASE EXACERBATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SCREENING; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EYE SURGERY; FEMALE; FOLLOW UP; FUSARIUM; FUSARIUM KERATITIS; HUMAN; KERATECTOMY; KERATOMYCOSIS; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OUTCOME ASSESSMENT; PENETRATING KERATOPLASTY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SUPERFICIAL KERATECTOMY; TREATMENT DURATION; VISUAL ACUITY; CORNEAL ULCER; EYE INFECTIONS, FUNGAL; MICROBIOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ADULT; ANTIFUNGAL AGENTS; CORNEAL ULCER; DOUBLE-BLIND METHOD; EYE INFECTIONS, FUNGAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NATAMYCIN; OPHTHALMIC SOLUTIONS; PROSPECTIVE STUDIES; VISUAL ACUITY; VORICONAZOLE;

EID: 84940607589     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2014-306485     Document Type: Article

References (20)

1. Bharathi MJ, Ramakrishnan R, Vasu S, et al. Epidemiological characteristics and laboratory diagnosis of fungal keratitis. Indian J Ophthalmol 2003;51:315-21.
2. Bunya VY, Hammersmith KM, Rapuano CJ, et al. Topical and oral voriconazole in the treatment of fungal keratitis. Am J Ophthalmol 2007;143:151-3.
3. Thiel MA, Zinkernagel AS, Burhenne J, et al. Voriconazole concentration in human aqueous humor and plasma during topical or combined topical and systemic administration for fungal keratitis. Antimicrob Agents Chemother 2007;51:239-44.
4. Prajna NV, Mascarenhas J, Krishnan T, et al. Comparison of Natamycin and Voriconazole for the treatment of fungal keratitis. Arch Ophthalmol 2010;128:672-8.
5. Prajna NV, Krishnan T, Mascarenhas J, et al. The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole. JAMA Opthalmol 2013;131:422-9.
6. Sutton DA, Sanche SE, Revankar SG, et al. In vitro amphotericin B resistance in clinical isolates of Aspergillus terreus, with a head-to-head comparison to voriconazole. J Clin Microbiol 1999;37:2343-5.
7. Hoffman HL, Rathburn RC. Review of the safety and efficacy of voriconazole. Expert Opin Investig Drugs 2002;11:409-29.
8. Gopinathan U, Sharma S, Garg P, et al. Review of epidemiological features, microbiological diagnosis and treatment outcome of microbial keratitis: experience of over a decade. Indian J Ophthalmol 2009;57:273-9.
9. Lalitha P, Prajna NV, Kabra A, et al. Risk factors for treatment outcome in fungal keratitis. Ophthalmology 2006;113:526-30.
10. Jones BR. Principles in the management of oculomycosis. Am J Ophthalmol 1975;79:719-51.
11. Lalitha P, Shapiro BL, Srinivasan M, et al. Antimicrobial susceptibility of Fusarium, Aspergillus and other filamentous fungi isolated from keratitis. Arch Ophthalmol 2007;125:789-93.
12. Yan X, Pang G, Gao C, et al. In vitro comparison of the efficacies of natamycin and silver nitrate against ocular fungi. Antimicrob Agents Chemother 2009;53:1636-8.
13. Creti A, Esposito V, Bocchetti M, et al. Voriconazole curative treatment for Acremonium species keratitis developed in a patient with concomitant Staphylococcus aureus corneal infection: a case report. In Vivo 2006;20:169-71.
14. Sponsel W, Chen N, Dang D, et al. Topical voriconazole as a novel treatment for fungal keratitis. Antimicrob Agents Chemother 2006;50:262-8.
15. Ozbek Z, Kang S, Sivalingam J, et al. Voriconazole in the management of Alternaria keratitis. Cornea 2006;25:242-4.
16. Klont RR, Eggink CA, Rijs AJ, et al. Successful treatment of Fusarium keratitis with cornea transplantation and topical and systemic voriconazole. Clin Infect Dis 2005;40:e110-12.
17. Lai TF, Malhotra R, Esmail-Zaden R, et al. Use of voriconazole in Scedosporium apiospermum keratitis. Cornea 2003;22:391; discussion 391-2.
18. Nulens E, Eggink C, Rijs AJ, et al. Keratitis caused by Scedosporium apiospermum successfully treated with a cornea transplant and voriconazole. J Clin Microbiol 2003;41:2261-4.
19. Sharma N, Chacko J, Velpandian T, et al. Comparative evaluation of topical versus intrastromal voriconazole as an adjunct to natamycin in recalcitrant fungal keratitis. Ophthalmology 2013;120:677-81.
20. Loh AR, Hong K, Lee S, et al. Practice patterns in the management of fungal corneal ulcers. Cornea 2009;28:856-9.